Skip to main
CRNX
CRNX logo

CRNX Earnings Dates & Reports

CRNX Most Recent Earnings

Report DateNov 6, 2025
Period EndingQ3 2025
Est. EPS-$1.26
Actual EPS-$1.38
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CRNX Earnings per Share (EPS) History

Signup for full access
Browse free

CRNX Latest Earnings

The value each CRNX share was expected to gain vs. the value each share gained.

CRNX reported its most recent earnings on Nov 6, 2025 for Q3 2025, posting earnings per share (EPS) of -$1.38. This exceeded analysts' expectations of -$1.26 by 9.52%, marking a Miss.

For comparison, Crinetics Pharmaceuticals Inc reported EPS of -$0.96 in the same quarter last year.

The company is expected to announce its next earnings report on 02/26/2026, with analysts projecting an EPS of -$1.35.

CRNX Earnings History

Earnings
Est. EPSActual EPSSurprise
Q4 2025Feb 26, 2026
-$1.35Next earnings call Feb. 26, 2026
Q3 2025Nov 6, 2025
-$1.26-$1.38+9.52%
DeckReportListen
Q2 2025Aug 7, 2025
-$1.11-$1.23+10.81%
DeckReportListen
Q1 2025May 8, 2025
-$0.95-$1.04+9.47%
DeckReportListen
Q4 2024Feb 27, 2025
-$0.89-$0.88-1.12%
DeckReportListen
View all

CRNX Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Crinetics Pharmaceuticals Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 6, 2025
Aug 7, 2025
May 8, 2025
Feb 27, 2025

CRNX Earnings FAQs

CRNX last reported earnings on Nov 6, 2025 for Q3 2025, posting an EPS of -$1.38, which Miss the estimate of -$1.26 by 9.52%.

For Q3 2025, CRNX reported an EPS of -$1.38, missing analysts' estimate of -$1.26 by 9.52%.

For Q3 2025, CRNX Miss expectations with an actual EPS of -$1.38 vs. an estimated EPS of -$1.26.

Following the last earnings report on Nov 6, 2025, CRNX's stock price moved — from — to —.

The next CRNX earnings call is scheduled for Feb. 26, 2026, where executives will discuss financial results and outlook.

Crinetics Pharmaceuticals Inc (CRNX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.